Clinical trial Recruiting at 4 sites Observational

Creating a national database for patients with parathyroid cancer and atypical adenoma in Italy

Official title: Creation, Management and Analysis of a National Database of Patients with Parathyroid Carcinoma or Atypical Parathyroid Adenoma

Run by F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore · NCT06645951 · Data updated 2026-11-12

This study is creating a national database to collect information about patients with parathyroid cancer and atypical adenoma in Italy to help improve their treatment and care.

Quick facts

Study typeObservational
SexAll
Enrollment300 (estimated)
SponsorF.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore
Academic / other
Locations33 sites (Bari and 32 other locations)
StatusRecruiting
StartedNovember 4, 2024
Main results expectedNovember 4, 2034
Study endsNovember 4, 2034
Registry record updatedJanuary 22, 2025
Trial IDNCT06645951 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals diagnosed with parathyroid carcinoma or atypical parathyroid adenoma.

Probably not a fit

Patients with other types of parathyroid tumors or those not diagnosed with parathyroid carcinoma or atypical adenoma may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to establish and manage a multicenter national database for patients diagnosed with parathyroid carcinoma or atypical parathyroid adenoma across Italy. The study will involve 33 specialized clinical centers and will collect both retrospective and prospective data over a 10-year period. Information gathered will include clinical, genetic, diagnostic, and therapeutic data to enhance understanding and management of these rare conditions. The goal is to refine clinical guidelines and improve patient outcomes through comprehensive data analysis.

Why it matters

Potential benefit: If successful, this study could lead to improved clinical management and treatment guidelines for patients with parathyroid carcinoma and atypical adenoma.

How similar studies have gone: While studies on parathyroid tumors are limited due to their rarity, the establishment of multicenter databases has shown promise in other rare conditions, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Cohort 1: parathyroid carcinoma
* Cohort 2: atypical parathyroid adenoma

Exclusion Criteria:

None

Where it's running

  • UO Endocrinologia e Malattie del Ricambio, Azienda Ospedaliero Universitaria di Ferrara, Sezione di Endocrinologia, Geriatria e Medicina Interna, Dipartimento di Scienze Mediche, Università degli Studi di Ferrara
    Ferrara, Italy
    Recruiting
  • SOD Malattie del Metabolismo Minerale ed Osseo, Azienda Ospedaliero-Universitaria Careggi
    Florence, Italy
    Recruiting
  • Dipartimento di Medicina Clinica e Chirurgia; Unità di Endocrinologia, Diabetologia e Andrologia; Università degli Studi di Napoli Federico II
    Naples, Italy
    Recruiting
  • Donatello Bone Clinic, Casa di Cura Villa Donatello
    Sesto Fiorentino, Italy
    Recruiting
  • U.O.C. Endocrinologia, Azienda Ospedaliero Universitaria Policlinico Consorziale, Università degli Studi di Bari "Aldo Moro"
    Bari, Italy
    Not yet recruiting
  • UOC Endocrinologia e Prevenzione e Cura del Diabete, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Dipartimento di Scienze Mediche e Chirurgiche (DIMEC), Alma Mater Studiorum Università di Bologna
    Bologna, Italy
    Not yet recruiting
Show 27 more locations
  • Endocrinologia e Diabetologia, Azienda Ospedaliero-Universitaria di Cagliari, Presidio Ospedaliero Policlinico di Monserrato
    Cagliari, Italy
    Not yet recruiting
  • Unità di Chirurgia Endocrina, Azienda Ospedaliero-Universitaria Careggi
    Florence, Italy
    Not yet recruiting
  • Ospedale Casa Sollievo della Sofferenza
    Foggia, Italy
    Not yet recruiting
  • Clinica Endocrinologica, Dipartimento di Medicina Interna e Specialità Mediche (DiMI), IRCCS Ospedale Policlinico San Martino, Università di Genova
    Genova, Italy
    Not yet recruiting
  • Clinica Pediatrica ed Endocrinologia, IRCCS Ospedale Pediatrico Giannina Gaslini
    Genova, Italy
    Not yet recruiting
  • U.O.S.D. Centro Malattie Rare · Dipartimento di Pediatria IRCCS Ospedale Pediatrico Giannina Gaslini
    Genova, Italy
    Not yet recruiting
  • UOC di Endocrinologia, AOU Policlinico G. Martino, Dipartimento di Patologia Umana DETEV, Università di Messin
    Messina, Italy
    Not yet recruiting
  • Dipartimento di Malattie Endocrino-Metaboliche, IRCCS Istituto Auxologico Italiano
    Milan, Italy
    Not yet recruiting
  • Endocrinologia Infantile, UOU di Pediatria, IRCCS Ospedale San Raffaele
    Milan, Italy
    Not yet recruiting
  • IRCCS Ospedale San Raffaele
    Milan, Italy
    Not yet recruiting
  • SC Endocrinologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
    Milan, Italy
    Not yet recruiting
  • UOC di Endocrinologia e Malattie del Metabolismo, AOU Università degli Studi della Campania Luigi Vanvitelli
    Naples, Italy
    Not yet recruiting
  • SCDU Endocrinologia Azienda Ospedaliero-Universitaria Maggiore della Carità di Novara
    Novara, Italy
    Not yet recruiting
  • Endocrinologia, Clinica Polispecialistica San Carlo
    Paderno Dugnano, Italy
    Not yet recruiting
  • Unità di Chirurgia Endocrina, Dipartimento di Chirurgia, Oncologia e Gastroenterologia, Università di Padova
    Padova, Italy
    Not yet recruiting
  • UOC Endocrinologia, DIMED, Azienda Ospedaliero-Universitaria di Padova
    Padova, Italy
    Not yet recruiting
  • Unità Operativa Endocrinologia 2, Azienda Ospedaliera Universitaria Pisana
    Pisa, Italy
    Not yet recruiting
  • Dipartimento di Medicina Sperimentale, "Sapienza" Università di Roma, Roma - UOC Endocrinologia, Policlinico Umberto I di Roma
    Roma, Italy
    Not yet recruiting
  • Unità di Endocrinologia e Andrologia, Dipartimento di Medicina Clinica e Molecolare, AOU Sant'Andrea, Centro di eccellenza ENETS, Università Sapienza di Roma
    Roma, Italy
    Not yet recruiting
  • UOC Patologie osteo-metaboliche e della tiroide, Fondazione Policlinico universitario Campus Bio-Medico
    Roma, Italy
    Not yet recruiting
  • UOC di Endocrinologia, Diabetologia e Andrologia Medica, IRCCS Humanitas Research Hospital
    Rozzano, Italy
    Not yet recruiting
  • Dipartimento di Scienze Mediche, Chirurgiche e Neuroscienze, Policlinico Santa Maria delle Scotte, Università di Siena
    Siena, Italy
    Not yet recruiting
  • SCDU Endocrinologia Diabetologia e Malattie del Metabolismo, AOU Città della Salute e della Scienza di Torino, Università di Torino
    Torino, Italy
    Not yet recruiting
  • SCDU Endocrinologia Oncologica, AOU Città della Salute e della Scienza di Torino, Università di Torino
    Torino, Italy
    Not yet recruiting
  • IRCCS Materno-Infantile Burlo Garofolo
    Trieste, Italy
    Not yet recruiting
  • SOC Endocrinologia, Azienda Sanitaria-Universitaria Friuli Centrale
    Udine, Italy
    Not yet recruiting
  • UOS di Endocrinologia, Policlinico GB Rossi, Azienda Ospedaliera Universitaria Integrata di Verona
    Verona, Italy
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.